(Q53649382)

16 May 2018

title

Clinical significance of hmgb1 expression in human gastric cancer. (English)

1 reference

16 May 2018

author name string

J Zhang

1

1 reference

16 May 2018

R Zhang

2

1 reference

16 May 2018

W W Lu

3

1 reference

16 May 2018

J S Zhu

4

1 reference

16 May 2018

L Q Xia

5

1 reference

16 May 2018

Y M Lu

6

1 reference

16 May 2018

N W Chen

7

1 reference

16 May 2018

publication date

1 October 2014

1 reference

16 May 2018

International Journal of Immunopathology and Pharmacology

published in

1 reference

16 May 2018

volume

27

1 reference

16 May 2018

issue

4

1 reference

16 May 2018

page(s)

543-551

1 reference

16 May 2018

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

High-mobility group protein B1 (HMGB1) is a novel biomarker for human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

High-mobility group box 1 (HMGB1) protein regulates tumor-associated cell migration through the interaction with BTB domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

Extracellular high mobility group box chromosomal protein 1 promotes drug resistance by increasing the expression of P‑glycoprotein expression in gastric adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

Growth suppression and radiosensitivity increase by HMGB1 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

The role of high mobility group box 1 (HMGB1) in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

Expression of RAGE and HMGB1 in thymic epithelial tumors, thymic hyperplasia and regular thymic morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

Expression and effects of high-mobility group box 1 in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

High Mobility Group Box1 (HMGB1) released from cancer cells induces the expression of pro-inflammatory cytokines in peritoneal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

Exogenous high-mobility group box 1 inhibits apoptosis and promotes the proliferation of lewis cells via RAGE/TLR4-dependent signal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

The association of HMGB1 gene with the prognosis of HCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201402700410

Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.3892/OR.2012.1623

Identifiers

DOI

10.1177/039463201402700410

1 reference

16 May 2018

1 reference

16 May 2018